CTOs on the Move

Animal Internal Medicine & Specialty Services -

www.aimss-sf.com

 
Animal Internal Medicine and Specialty Services (AIMSS) partners with Animal Emergency Services to provide the best specialty, emergency and critical pet care in the San Francisco Bay Area. We are locally owned and operated. Our team of board-certi...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.aimss-sf.com
  • 1333, 9th Avenue
    San Francisco, CA USA 94122
  • Phone: 415.566.0540

Executives

Name Title Contact Details

Similar Companies

Acom Healthcare

Acom Healthcare is a Hingham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Swan Hills - Family and Community Support Services

Swan Hills - Family and Community Support Services is a Swan Hills, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Canyon House and Crescent Villa

Canyon House and Crescent Villa is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Monarch Medical Technologies

Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.

ElectroCore

electroCore is, a US based electroceutical healthcare company, which is developing a range of non-invasive Vagus Nerve Stimulation (nVNS) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. Initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electroCore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the US (head office), Germany (German and European head office), UK, Italy, Australia, and Canada.